Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U.S. Renal Care is the largest privately held dialysis provider in the U.S., operating 400+ dialysis centers across 32-33 states, caring for more than 27,000 to 36,000 patients with chronic kidney disease and end-stage renal disease annually; its in-house Kidney Research team partners on and conducts clinical trials addressing medication management and patient care interventions, demonstrating superior clinical outcomes and frequent partnerships with leading nephrologists and federal agencies such as NIH.[1][2][3][4][6][7][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U.S. Renal Care.